Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maria Gaia Monti"'
Autor:
Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, Antonio Barbieri, Maria Gaia Monti, Andreina Carbone, Andrea Paccone, Lucia Altucci, Mariarosaria Conte, Maria Laura Canale, Gerardo Botti, Nicola Maurea
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-20 (2021)
Abstract Background Empagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter 2, reduced the risk of hospitalization for heart failure and cardiovascular death in type 2 diabetic patients in the EMPA‐REG OUTCOME trial. Recent
Externí odkaz:
https://doaj.org/article/a29aacd3beb14c22bf70f58d3376d71d
Autor:
Roberta D'Assante, Michele Arcopinto, Giuseppe Rengo, Andrea Salzano, Marion Walser, Giuseppina Gambino, Maria Gaia Monti, Leonardo Bencivenga, Alberto M. Marra, David N. Åberg, Carlo De Vincentiis, Andrea Ballotta, Eduardo Bossone, Jörgen Isgaard, Antonio Cittadini
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1681-1686 (2021)
Abstract Aims Limited data are available regarding cardiac expression of molecules involved in heart failure (HF) pathophysiology. The majority of the studies have focused on end‐stage HF with reduced ejection fraction (HFrEF) without comparison wi
Externí odkaz:
https://doaj.org/article/5aea43ea52114f3893784169cd9da9d6
Autor:
Michele Ciccarelli, Daniela Sorriento, Antonella Fiordelisi, Jessica Gambardella, Antonietta Franco, Carmine delGiudice, Marina Sala, Maria Gaia Monti, Alessia Bertamino, Pietro Campiglia, Marco Oliveti, Paolo Poggio, Giovanna Trinchese, Gina Cavaliere, Ersilia Cipolletta, Maria Pina Mollica, Domenico Bonaduce, Bruno Trimarco, Guido Iaccarino
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1571-1584 (2020)
Abstract Aims The effects of GRK2 inhibition on myocardial metabolism in heart failure (HF) are unchartered. In this work, we evaluated the impact of pharmacological inhibition of GRK2 by a cyclic peptide, C7, on metabolic, biochemical, and functiona
Externí odkaz:
https://doaj.org/article/e81b5044fb7e45569835835d35abf720
Autor:
Patrizia Fabbi, Paolo Spallarossa, Silvano Garibaldi, Chiara Barisione, Marzia Mura, Paola Altieri, Barbara Rebesco, Maria Gaia Monti, Marco Canepa, Giorgio Ghigliotti, Claudio Brunelli, Pietro Ameri
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124643 (2015)
Insulin-like growth factor-1 (IGF-1) promotes the survival of cardiomyocytes by activating type 1 IGF receptor (IGF-1R). Within the myocardium, IGF-1 action is modulated by IGF binding protein-3 (IGFBP-3), which sequesters IGF-1 away from IGF-1R. Sin
Externí odkaz:
https://doaj.org/article/7873e7f011504a0fbd4313266562c921
Autor:
Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, Antonio Barbieri, Maria Gaia Monti, Antonietta Caronna, Annamaria Bonelli, Gerardo Botti, Nicola Maurea
BackgroundEmpagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter 2, reduced the risk of hospitalization for heart failure and cardiovascular death in type 2 diabetic patients in the EMPA‐REG OUTCOME trial. Other clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2009adb30718b9e666b4fb906df088
https://doi.org/10.21203/rs.3.rs-97968/v1
https://doi.org/10.21203/rs.3.rs-97968/v1
Autor:
Domenica, Rea, Carmela, Coppola, Antonio, Barbieri, Maria Gaia, Monti, Gabriella, Misso, Giuseppe, Palma, Sabrina, Bimonte, Mayra Rachele, Zarone, Antonio, Luciano, Davide, Liccardo, Piera, Maiolino, Antonio, Cittadini, Gennaro, Ciliberto, Claudio, Arra, Nicola, Maurea
Publikováno v:
In vivo (Athens, Greece). 30(3)
In recent years, the development of more effective anticancer drugs has provided great benefits in patients' quality of life by improving both prognosis and disease-free survival. Nevertheless, the frequency and severity of side-effects, with particu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e8af886ab6424de801c16ca45bb908c
https://pubmed.ncbi.nlm.nih.gov/27107087
https://pubmed.ncbi.nlm.nih.gov/27107087
Publikováno v:
Italian heart journal : official journal of the Italian Federation of Cardiology. 6
Aldosterone was discovered in 1953, and until the beginning of the 1960s, when spironolactone was developed, it was the focus of considerable interest among the scientific community. The following 30 years represented a sort of Dark Age, interrupted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d8b09ad56ffabbb066f615ce0da4ab5
https://pubmed.ncbi.nlm.nih.gov/15945299
https://pubmed.ncbi.nlm.nih.gov/15945299
Autor:
Antonio, Cittadini, Cosma, Casaburi, Maria Gaia, Monti, Angela, Di Gianni, Raffaella, Serpico, Giovanna, Scherillo, Lavinia, Saldamarco, Massimo, Vanasia, Luigi, Saccà
Publikováno v:
Cardiovascular drugs and therapy. 16(3)
Spironolactone reduces overall mortality by 30% in advanced congestive heart failure. Nevertheless, few data are available with regard to the effects of mineral corticoid inhibition in postinfarction heart failure.Experimental myocardial infarction w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5a15d5db2f887772898c89015cf815f
https://pubmed.ncbi.nlm.nih.gov/12374894
https://pubmed.ncbi.nlm.nih.gov/12374894
Autor:
Palmieri, Ea, Benincasa, G., Di Rella, F., Casaburi, C., Maria Gaia Monti, Simone, G., Chiariotti, L., Palombini, L., Bruni, Cb, Sacca, L., Cittadini, A.
Publikováno v:
ResearcherID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7cef1b3f93cbc9ee4b55f84de2842fc5
http://hdl.handle.net/11588/183003
http://hdl.handle.net/11588/183003
Autor:
Maria Gaia Monti, Antonio Cittadini
Publikováno v:
European Heart Journal. 24:526
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::407ba8079074f4641ee35df0e38b5fcd
https://doi.org/10.1016/s0195-668x(03)95574-6
https://doi.org/10.1016/s0195-668x(03)95574-6